Promoter methylation is associated with the age-dependent loss of N-cadherin in the rat kidney

American Journal of Physiology - Renal Physiology

Volumn 294, Issue 1, 2008, Pages

  Akintola, Adebayo D ^a   Crislip, Zachary L ^a   Catania, Jeffrey M ^b   Chen, Gang ^a   Zimmer, Warren E ^a   Burghardt, Robert C ^b   Parrish, Alan R ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b Citrus Center   (United States)

Author keywords

Adherens junction; Aging; Caloric restriction

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE INHIBITOR; NERVE CELL ADHESION MOLECULE; NUCLEOTIDE;

AGE; AGING; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA FLANKING REGION; DNA METHYLATION; KIDNEY; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT;

EID: 38348998901     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00285.2007     Document Type: Article

References (42)

1. Attwood JT, Yung RL, Richardson BC. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci 59: 241-257, 2002.
2. Brezis M, Epstein FH. A closer look at radiocontrast-induced nephropathy. N Engl J Med 320: 179-181, 1989.
3. Burzynski SR. Gene silencing - a new theory of aging. Med Hypotheses 60: 578-583, 2003.
4. Chen Q, Lipkina G, Song Q, Kramer RH. Promoter methylation regulates cadherin switching in squamous cell carcinoma. Biochem Biophys Res Commun 315: 850-856, 2004.
5. Cho JH, Kimura H, Minami T, Ohgane J, Hattori N, Tanaka S, Shiota K. DNA methylation regulates placental lactogen I gene expression. Endocrinology 142: 3389-3396, 2001.
6. Christman JK. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21: 5483-5495, 2002.
7. Costello JF, Plass C. Methylation matters. J Med Genet 38: 285-303, 2001.
8. Creusot F, Acs G, Christman JK. Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2′-deoxycytidine. J Biol Chem 257: 2041-2048, 1982.
9. Epstein M. Aging and the kidney. J Am Soc Nephrol 7: 1106-1122, 1996.
10. Goomer RS, Maris T, Amiel D. Age-related changes in the expression of cadherin-11, the mesenchyme specific calcium-dependent cell adhesion molecule. Calcif Tissue Int 62: 532-537, 1998.
11. Hagihara A, Miyamoto K, Furuta J, Hiraoka N, Wakazono K, Seki S, Fukushima S, Tsao MS, Sugimura T, Ushijima T. Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene 23: 8705-8710, 2004.
12. Henger A, Kretzler M, Doran P, Bonrouhi M, Schmid H, Kiss E, Cohen CD, Madden S, Porubsky S, Grone EF, Schlondorff D, Nelson PJ, Grone HJ. Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int 65: 904-917, 2004.
13. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
14. Husmark J, Heldin NE, Nilsson M. N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines. Int J Cancer 83: 692-699, 1999.
15. Issa JP. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 249: 101-118, 2000.
16. Jassal SV, Oreopoulos DG. The aging kidney. Geriatr Nephrol Urol 8: 141-147, 1998.
17. Jhaveri MS, Wagner C, Trepel JB. Impact of extracellular folate levels on global gene expression. Mol Pharmacol 60: 1288-1295, 2001.
18. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 20: 85-93, 1980.
19. Jung KY, Dean D, Jiang J, Gaylor S, Griffith WH, Burghardt RC, Parrish AR. Loss of N-cadherin and alpha-catenin in the proximal tubules of aging male Fischer 344 rats. Mech Ageing Dev 125: 445-453, 2004.
20. Le Mee S, Fromigue O, Marie PJ. Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp Cell Res 302: 129-142, 2005.
21. Li B, Paradies NE, Brackenbury RW. Isolation and characterization of the promoter region of the chicken N-cadherin gene. Gene 191: 7-13, 1997.
22. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431, 2002.
23. Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50: 811-818, 1996.
24. McLachlan M, Wasserman P. Changes in sizes and distensibility of the aging kidney. Br J Radiol 54: 488-491, 1981.
25. Ng HH, Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev 9: 158-163, 1999.
26. Prozialeck WC, Lamar PC, Appelt DM. Differential expression of E-cadherin, N-cadherin and beta-catenin in proximal and distal segments of the rat nephron. BMC Physiol 4: 10, 2004.
27. Ribeiro-Filho LA, Franks J, Sasaki M, Shiina H, Li LC, Nojima D, Arap S, Carroll P, Enokida H, Nakagawa M, Yonezawa S, Dahiya R. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinog 34: 187-198, 2002.
28. Richardson B. Impact of aging on DNA methylation. Ageing Res Rev 2: 245-261, 2003.
29. Rocha AS, Soares P, Seruca R, Maximo V, Matias-Guiu X, Cameselle-Teijeiro J, Sobrinho-Simoes M. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol 194: 358-366, 2001.
30. Saito Y, Takazawa H, Uzawa K, Tanzawa H, Sato K. Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5′ CpG island. Int J Oncol 12: 293-298, 1998.
31. Sasaki M, Anast J, Bassett W, Kawakami T, Sakuragi N, Dahiya R. Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation. Biochem Biophys Res Commun 309: 305-309, 2003.
32. Sheng W, Wang G, La Pierre DP, Wen J, Deng Z, Wong CK, Lee DY, Yang BB. Versican mediates mesenchymal-epithelial transition. Mol Biol Cell 17: 2009-2020, 2006.
33. Szyf M. DNA methylation and cancer therapy. Drug Resist Updat 6: 341-353, 2003.
34. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 7: 619-627, 1995.
35. Tollefsbol TO, Andrews LG. Mechanisms for methylation-mediated gene silencing and aging. Med Hypotheses 41: 83-92, 1993.
36. Wagner MC, Molitoris BA. Renal epithelial polarity in health and disease. Pediatr Nephrol 13: 163-170, 1999.
37. Xu B, Sano T, Yoshimoto K, Yamada S. Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies. Endocr Pathol 13: 341-351, 2002.
38. Yamashita S, Tsujino Y, Moriguchi K, Tatematsu M, Ushijima T. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci 97: 64-71, 2006.
39. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92: 7416-7419, 1995.
40. Young DC, Kingsley SD, Ryan KA, Dutko FJ. Selective inactivation of eukaryotic beta-galactosidase in assays for inhibitors of HIV-1 TAT using bacterial beta-galactosidase as a reporter enzyme. Anal Biochem 215: 24-30, 1993.
41. Xue JL, Daniels F, Star RA, Kimmel PL, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17: 1135-1142, 2006.
42. Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H, Yee L, Villalona-Calero MA, Plass C, Otterson GA. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol Cell Biol 23: 4056-4065, 2003.